BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

PURDUE PHARMA — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

PURDUE PHARMA

via DENTONS US LLP

1st Quarter (Jan 1 - Mar 31) · 2016Posted Apr 19, 2016Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: PURDUE PHARMA
Description: Pharmaceutical manufacturer
Location: Canada

Registrant

Firm: DENTONS US LLP
Description: Law Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
U.S. and Canadian regulatory policies regarding prescription drug abuse
Lobbyistsms MEGAN M. DELANY · ANDREW SHAW
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.